Inositol
Beans, citrus fruits, cantaloupe, whole grains, nuts.
Tag
PCOS references connect insulin-resistance marker context, inositol, omega-3, chromium, vitamin D, magnesium, and supplement safety limitations.
| Item | Type | Relationship | Evidence |
|---|---|---|---|
| Inositol | bioactive | May Support | Systematic reviews discuss possible benefits and important evidence-quality limits. Systematic Review |
| Omega-3 Fish Oil | bioactive | Caution / Limited Evidence | PCOS systematic-review context plus NIH ODS omega-3 safety framing. Systematic Review |
| Chromium | nutrient | Caution / Limited Evidence | PCOS network meta-analysis context plus official chromium source framing. Systematic Review |
| Vitamin D | nutrient | Caution / Limited Evidence | PCOS content uses official vitamin D source trail rather than broad treatment claims. Official Reference |
| Berberine | bioactive | Caution / Limited Evidence | Marker-level evidence should not override high-caution medication and pregnancy context. Systematic Review |
| Cinnamon | bioactive | Caution / Limited Evidence | Keep as cautious metabolic-marker context, not PCOS treatment guidance. Systematic Review |
Beans, citrus fruits, cantaloupe, whole grains, nuts.
Salmon, sardines, mackerel, herring, anchovies.
Use authoritative food-composition data in the food-source module..
Fatty fish, Fortified milk or plant beverages, Egg yolk.
Barberry, goldenseal, Oregon grape, goldthread.
Ceylon cinnamon bark, cassia cinnamon bark.
Inositol is one of the most common PCOS supplement topics, with marker-level evidence but uncertainty around form, ratio, dose, and safety certainty. | pregnancy/breastfeeding | fertility treatment | diabetes medications
Omega-3 supplements are studied in PCOS marker contexts, including insulin-resistance and lipid markers, but high-dose use needs bleeding-risk review. | blood thinners | bleeding risk | surgery
Chromium is studied in glucose and PCOS marker contexts, but evidence is not a reason for unsupervised high-dose use.
Vitamin D status is often discussed in PCOS, but supplementation should follow ordinary DRI/UL, testing, and safety context. | Avoid chronic high-dose use above the UL without medical supervision.
Berberine has glucose and lipid marker evidence but carries medication, pregnancy, breastfeeding, antibiotic, infant, and transplant cautions. | pregnancy/breastfeeding | diabetes medications | blood pressure medications
Cinnamon is studied for glucose markers and PCOS-related metabolic contexts, but species, coumarin, liver disease, anticoagulants, and diabetes medicines matter. | liver disease | blood thinners | diabetes medications
These are the dated references used for this tag. Live research searches can change; these links explain the fixed wording shown on this page.
BMC Complementary and Alternative Medicine / PubMed Central | Acquired 2026-08-03 | Systematic Review
PCOS supplement evidence limitations, Inositol low-quality evidence, Omega-3 PCOS context.
Frontiers / PubMed Central | Acquired 2026-08-03 | Systematic Review
PCOS supplement network meta-analysis, Inositol lipid markers, Omega-3 insulin resistance marker context.
NIH Office of Dietary Supplements | Acquired 2026-07-23 | Official Reference
ALA AI, EPA/DHA no official DRI, Fish, krill, algal, and plant omega sources.
NIH Office of Dietary Supplements | Acquired 2026-07-24 | Official Reference
Chromium and insulin action, Blood glucose marker context, Chromium supplement evidence limitations.
Health Canada | Acquired 2026-07-23 | Official Reference
Canadian DRI table display, Vitamin D and K reference values, Vitamin K no-UL caution.
European Food Safety Authority | Acquired 2026-07-23 | Official Reference
EU vitamin D adequate intake, 25(OH)D target context, Minimal sun exposure assumption.
Frontiers in Pharmacology / PubMed | Acquired 2026-07-23 | Systematic Review
Berberine glucose markers, Berberine diabetes-study context.
National Center for Complementary and Integrative Health | Acquired 2026-08-03 | Traditional / Safety Reference
Type 2 diabetes supplement caution, Berberine chromium cinnamon evidence limits, Diabetes medication safety.
U.S. Food and Drug Administration | Acquired 2026-07-23 | Government Health Agency
Supplement-medication interaction warning language.
Inositol is one of the most common PCOS supplement topics, with marker-level evidence but uncertainty around form, ratio, dose, and safety certainty.
Evidence note: Systematic reviews discuss possible benefits and important evidence-quality limits.
Sources: Nutritional Supplements and Herbal Medicines for Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis (2026-08-03)Systematic Review, The Effectiveness of Nutritional Supplements in Improving Polycystic Ovary Syndrome in Women: A Systematic Review and Network Meta-Analysis (2026-08-03)Systematic Review
Omega-3 supplements are studied in PCOS marker contexts, including insulin-resistance and lipid markers, but high-dose use needs bleeding-risk review.
Evidence note: PCOS systematic-review context plus NIH ODS omega-3 safety framing.
Sources: Nutritional Supplements and Herbal Medicines for Women With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis (2026-08-03)Systematic Review, The Effectiveness of Nutritional Supplements in Improving Polycystic Ovary Syndrome in Women: A Systematic Review and Network Meta-Analysis (2026-08-03)Systematic Review, Omega-3 Fatty Acids Fact Sheet for Health Professionals (2026-07-23)Official Reference
Chromium is studied in glucose and PCOS marker contexts, but evidence is not a reason for unsupervised high-dose use.
Evidence note: PCOS network meta-analysis context plus official chromium source framing.
Sources: The Effectiveness of Nutritional Supplements in Improving Polycystic Ovary Syndrome in Women: A Systematic Review and Network Meta-Analysis (2026-08-03)Systematic Review, Chromium Fact Sheet for Health Professionals (2026-07-24)Official Reference
Vitamin D status is often discussed in PCOS, but supplementation should follow ordinary DRI/UL, testing, and safety context.
Evidence note: PCOS content uses official vitamin D source trail rather than broad treatment claims.
Sources: Dietary Reference Intakes Tables: Reference Values for Vitamins (2026-07-23)Official Reference, Dietary Reference Values for Vitamin D (2026-07-23)Official Reference
Berberine has glucose and lipid marker evidence but carries medication, pregnancy, breastfeeding, antibiotic, infant, and transplant cautions.
Evidence note: Marker-level evidence should not override high-caution medication and pregnancy context.
Sources: Glucose-Lowering Effect of Berberine on Type 2 Diabetes: Systematic Review and Meta-Analysis (2026-07-23)Systematic Review, 5 Things To Know About Type 2 Diabetes and Dietary Supplements (2026-08-03)Traditional / Safety Reference, Mixing Medications and Dietary Supplements Can Endanger Your Health (2026-07-23)Government Health Agency
Cinnamon is studied for glucose markers and PCOS-related metabolic contexts, but species, coumarin, liver disease, anticoagulants, and diabetes medicines matter.
Evidence note: Keep as cautious metabolic-marker context, not PCOS treatment guidance.
Sources: The Effectiveness of Nutritional Supplements in Improving Polycystic Ovary Syndrome in Women: A Systematic Review and Network Meta-Analysis (2026-08-03)Systematic Review, 5 Things To Know About Type 2 Diabetes and Dietary Supplements (2026-08-03)Traditional / Safety Reference, Mixing Medications and Dietary Supplements Can Endanger Your Health (2026-07-23)Government Health Agency